Literature DB >> 324626

Adriamycin and cyclophosphamide in advanced bladder cancer.

A Yagoda, R C Watson, H Grabstald, W E Barzell, W F Whitmore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324626

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

1.  Three-drug combination chemotherapy for advanced urothelial tract carcinoma.

Authors:  S Ohshima; Y Ono; T Fujita; Y Aso
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 2.  Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.

Authors:  F M Torti; W G Harker
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center.

Authors:  A Yagoda
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract.

Authors:  T Kotake; M Usami; T Miki; M Kuroda; K Obata; M Osafune; H Fujioka; Y Takasugi
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  Combination chemotherapy for advanced urothelial-tract carcinoma.

Authors:  M Sahashi; Y Ono; O Matsuura; S Ohshima; M Fukushima
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 6.  Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Authors:  R S Miller; F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Cytotoxic chemotherapy in carcinoma of the bladder: a review.

Authors:  P H Smith
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.